Correlation Between Vascular Endothelial Growth Factor and Long-Term Occurrence of HCV-Related Hepatocellular Carcinoma After Treatment with Direct-Acting Antivirals-Reference-Cited by-同舟云学术

Correlation Between Vascular Endothelial Growth Factor and Long-Term Occurrence of HCV-Related Hepatocellular Carcinoma After Treatment with Direct-Acting Antivirals

Published:2021-07-15 Issue:8 Volume:39 Page:653-660
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Ramadan Haidi K.¹^ORCID,Meghezel El-Zahraa M.²^ORCID,Abdel-Malek Mohammed O.¹,Askar Ashraf A.³,Hetta Helal F.⁴⁵^ORCID,Mahmoud Amal A.⁶,Abdel-Aal Amal M.⁶

Affiliation:

1. Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University, Assiut, Egypt

2. Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Sohag University, Sohag, Egypt

3. Department of Internal Medicine, Faculty of Medicine, Sohag University, Sohag, Egypt

4. Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt

5. Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA

6. Department of Clinical Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2021.1951751

Reference55 articles.

1. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

2. Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes

3. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma

4. Epidemiology of Hepatocellular Carcinoma

Cytotoxic Chemotherapy as an Alternative for Systemic Treatment of Advanced Hepatocellular Carcinoma in Developing Countries

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication;Clinical and Molecular Hepatology;2024-07-01

2. Vascular Endothelial Growth Factor (VEGF) in Liver Disease;Tumor Angiogenesis and Modulators;2022-07-27

3. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV;Livers;2021-12-14